subscribeSubscribe
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA

Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA
PR NEWSWIRE
26 Jun 2024
Share Share
Biond Biologics Doses First Patient With BND-35 In Phase 1 Clinical Trial

Biond Biologics Doses First Patient With BND-35 In Phase 1 Clinical Trial
PR NEWSWIRE
24 Jun 2024
Share Share
US FDA approves Bristol Myers` colorectal cancer therapy

US FDA approves Bristol Myers` colorectal cancer therapy
Christy Santhosh REUTERS
22 Jun 2024
Share Share
GenFleet`s Fulzerasib Combo Shows Efficacy, Safety In Phase II NSCLC Trial

GenFleet`s Fulzerasib Combo Shows Efficacy, Safety In Phase II NSCLC Trial
PR NEWSWIRE
01 Jun 2024
Share Share
ASCO 2024: Rakuten’s photoimmunotherapy & Keytruda combo shows efficacy in HNSCC

ASCO 2024: Rakuten’s photoimmunotherapy & Keytruda combo shows efficacy in HNSCC
Phalguni Deswal PHARMACEUTICAL TECHNOLOGY
28 May 2024
Share Share
Tizona Ttx-080 Phase 1b Data: Crc And Hnscc At Asco 2024

Tizona Ttx-080 Phase 1b Data: Crc And Hnscc At Asco 2024
GLOBENEWSWIRE
23 May 2024
Share Share
KRAZATI with Cetuximab Demonstrates Clinically Meaningful Activity

KRAZATI with Cetuximab Demonstrates Clinically Meaningful Activity
BUSINESSWIRE
08 Apr 2024
Share Share
FDA Accepts sNDA for KRAZATI in Combination with Cetuximab

FDA Accepts sNDA for KRAZATI in Combination with Cetuximab
BUSINESSWIRE
20 Feb 2024
Share Share
Nature Medicine Study Validates Biopsy Assay in Genentech`s Ph 1b of Divarasib

Nature Medicine Study Validates Biopsy Assay in Genentech`s Ph 1b of Divarasib
GLOBENEWSWIRE
11 Dec 2023
Share Share
Lupin launches biosimilar cetuximab in pact with Enzene

Lupin launches biosimilar cetuximab in pact with Enzene
Viswanath Pilla ECONOMICTIMES
30 May 2023
Share Share